Pharma & Biotech

The future of Kezar Life Sciences hangs in the balance following a devastating regulatory development that has forced the biotechnology...

The pharmaceutical firm Organon & Co. is confronting its most severe corporate challenge to date following the discovery of manipulated...

Biomea Fusion's stock remains under intense selling pressure, extending its downward trajectory for the fourth consecutive session. The equity declined...

Semler Scientific finds itself navigating treacherous waters as a potential rescue acquisition and substantial Bitcoin holdings fail to stem mounting...

Pharmaceutical giant Bristol-Myers Squibb has demonstrated a remarkable turnaround, with its latest quarterly report exceeding investor expectations through unexpectedly robust...

Co-Diagnostics shares experienced a severe market downturn after the company initiated a substantial equity offering at a deeply discounted price....

PDS Biotechnology Corp has taken a decisive step in its regulatory strategy, potentially altering the trajectory for its lead immunotherapy...

Biotechnology leader Amgen finds itself at a critical juncture as Tuesday's quarterly earnings release approaches, with market participants closely monitoring...

The pharmaceutical sector is witnessing a dramatic takeover contest as Pfizer confronts an unexpected challenge to its previously agreed acquisition....

Bionxt Solutions, a Canadian life sciences company, has achieved a significant regulatory milestone with the Eurasian Patent Organization (EAPO) granting...